MammoSite^® targeted radiation therapy is the only breast brachytherapy balloon with 5-year efficacy data. It was used to treat 1,440 patients with early stage breast cancer with a median follow-up of 54 months.¹

5-days versus 5-weeks turns a woman from patient to advocate.

The MammoSite Multi-lumen is now available with a 3.5 cm – 5.0 cm diameter, allowing for treatment in a broader spectrum of patient's cavities.
 

You have options when it comes to breast biopsy.  With the Celero^® breast biopsy device you can expect high quality cores with fewer insertions than traditional spring-loaded core devices. 

SecurMark^® for Celero and SecurMark Ultrasound are the perfect biopsy site markers for ultrasound. With our suture-like material, it is easily visualized under ultrasound and comes in multiple permanent shapes.

There are millions of women worldwide who can’t access or afford the most basic care. We need to change that. We’re starting with Promise to Me.